File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib

TitlePotential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib
Authors
Wang, HMa, XGuan, XSong, CLi, GYu, YMYang, LL
Issue Date2022
Citation
Pharmacological Research, 2022, v. 177, p. 106050 How to Cite?
DOI: http://dx.doi.org/10.1016/j.phrs.2021.106050
Persistent Identifierhttp://hdl.handle.net/10722/314507
ISI Accession Number ID
WOS:000788113100002

 

DC FieldValueLanguage
dc.contributor.authorWang, H-
dc.contributor.authorMa, X-
dc.contributor.authorGuan, X-
dc.contributor.authorSong, C-
dc.contributor.authorLi, G-
dc.contributor.authorYu, YM-
dc.contributor.authorYang, LL-
dc.date.accessioned2022-07-22T05:25:51Z-
dc.date.available2022-07-22T05:25:51Z-
dc.date.issued2022-
dc.identifier.citationPharmacological Research, 2022, v. 177, p. 106050-
dc.identifier.urihttp://hdl.handle.net/10722/314507-
dc.languageeng-
dc.relation.ispartofPharmacological Research-
dc.titlePotential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib-
dc.typeArticle-
dc.identifier.emailGuan, X: xyguan@hku.hk-
dc.identifier.authorityGuan, X=rp00454-
dc.identifier.doi10.1016/j.phrs.2021.106050-
dc.identifier.hkuros334437-
dc.identifier.volume177-
dc.identifier.spage106050-
dc.identifier.epage106050-
dc.identifier.isiWOS:000788113100002-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats